A Phase II Clinical Study of SYH2068 Injection in Adults With Elevated Lipoprotein(a)

NCT07640217 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Adult Participants With Elevated Lipoprotein(a)

Interventions

DRUG: SYH2068 Dose 1
DRUG: SYH2068 Dose 2
DRUG: SYH2068 Dose 3
DRUG: Placebo

Sponsor

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.